Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
NCT07797673Phase 1Recruiting
- Sponsor
- Dr. Cipto Mangunkusumo Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in biliary atresia comparing UC-MSC Group with Placebo Group (2 arms). Primary endpoint: Total Bilirubin Level at Day 180. Started Sep 2026; status: recruiting.
02
Drugs
umbilical cord-mesenchymal stem cells
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT07797673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797673.